Search Results

The global market for tissue engineered skin substitutes is consolidated in nature as a large share of the market is being held by three leading players, namely Smith & Nephew, Molnlycke, and Acelity, states a new research study by Transparency Market Research.

This exciting partnership brings together Mölnlycke’s outstanding expertise in wound care and Tissues Analytics’ advanced digital capabilities.

The global market for tissue engineered skin substitutes is consolidated in nature as a large share of the market is being held by three leading players, namely Smith & Nephew, Molnlycke, and Acelity, states a new research study by Transparency Market Research.

Leslie McDonnell has more than 20 years of experience in the Medtech industry through executive leadership roles at Medtronic, 3M Healthcare, and Natus Medical.

StimLabs, a leading regenerative medicine company, announced Institutional Review Board (IRB) authorization to begin the CAMPSTIM clinical trial, a multi-center randomized controlled trial to demonstrate the real-world benefits of StimLabs’ placental-based tissue products in treating patients with hard-to-heal diabetic foot ulcers (DFUs).